Literature DB >> 20708002

Dysregulation of microRNAs in cancer: playing with fire.

Sonia A Melo1, Manel Esteller.   

Abstract

MicroRNAs have emerged as key post-transcriptional regulators of gene expression, involved in various physiological and pathological processes. It was found that several miRNAs are directly involved in human cancers, including lung, breast, brain, liver, colon cancer and leukemia. In addition, some miRNAs may function as oncogenes or tumor suppressors in tumor development. Furthermore, a widespread down-regulation of miRNAs is commonly observed in human cancers and promotes cellular transformation and tumorigenesis. More than 50% of miRNA genes are located in cancer-associated genomic regions or in fragile sites, frequently amplified or deleted in human cancer, suggesting an important role in malignant transformation. A better understanding of the miRNA regulation and misexpression in cancer may ultimately yield further insight into the molecular mechanisms of tumorigenesis and new therapeutic strategies may arise against cancer. Here, we discuss the occurrence of the deregulated expression of miRNAs in human cancers and their importance in the tumorigenic process.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708002     DOI: 10.1016/j.febslet.2010.08.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  127 in total

Review 1.  Regulation of senescence by microRNA biogenesis factors.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Min-Ju Kang; Myriam Gorospe
Journal:  Ageing Res Rev       Date:  2012-01-28       Impact factor: 10.895

2.  Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells.

Authors:  Chun Chen; William T Baumann; Robert Clarke; John J Tyson
Journal:  FEBS Lett       Date:  2013-08-28       Impact factor: 4.124

3.  HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells.

Authors:  Maryline Santerre; Wissam Chatila; Ying Wang; Ruma Mukerjee; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2019-01-06       Impact factor: 4.534

Review 4.  MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.

Authors:  Joana Ribeiro; Hugo Sousa
Journal:  Mol Biol Rep       Date:  2014-01-09       Impact factor: 2.316

Review 5.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

6.  Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Yun Xie; Qinwei Yao; Azeem Mehmood Butt; Jia Guo; Zhou Tian; Xuli Bao; Hongxia Li; Qinghua Meng; Jun Lu
Journal:  Cancer Biol Ther       Date:  2014-06-27       Impact factor: 4.742

7.  MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/β-catenin signaling by repressing the expression of Quaking proteins.

Authors:  Zhejia Zhang; Xinying Li; Qian Xiao; Zhiming Wang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

Review 8.  Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.

Authors:  Bethany N Hannafon; Wei-Qun Ding
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

9.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

10.  There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Authors:  Rolf K Swoboda; Meenhard Herlyn
Journal:  Exp Dermatol       Date:  2013-03-12       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.